ClinicalTrials.Veeva

Menu

Minimally Invasive Surgery: Using Natural Orfices (NOTES)

University of California San Diego logo

University of California San Diego

Status

Completed

Conditions

Gallstones
Appendicitis
Cholelithiasis

Treatments

Procedure: Transvaginal Appendectomy
Procedure: Transvaginal Cholecystectomy

Study type

Observational

Funder types

Other

Identifiers

NCT00530998
071115, 140015

Details and patient eligibility

About

This is an observational study of pain and outcomes from females undergoing transvaginal NOTES removal of their appendix or gallbladder. Female subjects who elect to have a transvaginal NOTES removal of their appendix or gallbladder and agree to be in this study (through signature on the informed consent form) will be followed per standard of care, with additional follow-up for data collection including the following:

  • Subjects will complete a 7 day pain/temperature log after surgery
  • Subjects will complete a standardized sexual function questionnaire (Female Sexual Function Index) prior to surgery and 6 months after surgery
  • Subjects will receive a phone call at 6 months and at 1 year after surgery to capture data related to safety, adverse events, hospitalizations and patient satisfaction

Additional data related to pain and outcomes will be collected at baseline/screening and at follow-up as necessary.

Enrollment

120 patients

Sex

Female

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria for transvaginal appendectomy:

  1. Females between the ages of 18-75
  2. Clinical diagnosis of appendicitis
  3. Emergency room evaluation within 36 hours of the onset of pain
  4. ASA Classification 1
  5. Mentally competent to give informed consent
  6. Scheduled to undergo a transvaginal NOTES appendectomy.

Exclusion criteria for transvaginal appendectomy:

  1. Pregnant women (need to have negative icon in ER)
  2. Morbidly obese patients (BMI >35)
  3. Patients who are taking immunosuppressive medications or are immunocompromised
  4. Patients with evidence of an abdominal abscess or mass
  5. Patients who present with a clinical diagnosis of sepsis or peritonitis
  6. Patients who have a history of prior transvaginal surgery. Patients with prior laparoscopic surgery will be included.
  7. Patients who endorse a history of ectopic pregnancy, pelvic inflammatory disease (PID), or severe endometriosis
  8. Patients with diffuse peritonitis on clinical exam
  9. Patients on blood thinners or aspirin or abnormal blood coagulation tests

Inclusion criteria for transvaginal cholecystectomy:

  1. Females between the ages of 18 and 75
  2. Diagnosis of gallstone disease which requires cholecystectomy
  3. ASA class 1
  4. Mentally competent to give informed consent
  5. Scheduled to undergo a transvaginal NOTES cholecystectomy

Exclusion criteria for transvaginal cholecystectomy:

  1. Pregnant women
  2. Morbidly obese patients (BMI > 35)
  3. Patients who are taking immunosuppressive medications and/or immunocompromised
  4. Patients with severe medical comorbidities will be excluded.
  5. Patients with a presumed gallbladder polyps, mass or tumor
  6. Patients with a history of prior transvaginal surgery. Patients with prior laparoscopic surgery will be included.
  7. Patients with a history of ectopic pregnancy, pelvic inflammatory disease, or severe endometriosis
  8. Patients with known common bile duct stones
  9. Patients on blood thinners or aspirin or abnormal blood coagulation tests

Trial design

120 participants in 2 patient groups

1
Description:
Group #1 NOTES Appendectomy - Transvaginal approach
Treatment:
Procedure: Transvaginal Appendectomy
2
Description:
Group #2 NOTES Cholecystectomy - Transvaginal approach
Treatment:
Procedure: Transvaginal Cholecystectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems